Free Trial
NASDAQ:ACOG

Alpha Cognition Q2 2025 Earnings Report

Alpha Cognition logo
$9.13 -0.22 (-2.35%)
As of 08/7/2025 04:00 PM Eastern

Alpha Cognition EPS Results

Actual EPS
N/A
Consensus EPS
-$0.84
Beat/Miss
N/A
One Year Ago EPS
N/A

Alpha Cognition Revenue Results

Actual Revenue
N/A
Expected Revenue
$2.32 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Alpha Cognition Announcement Details

Quarter
Q2 2025
Time
After Market Closes
Conference Call Date
Thursday, August 14, 2025
Conference Call Time
4:30PM ET

Conference Call Resources

Alpha Cognition Earnings Headlines

Musk’s Project Colossus could mint millionaires
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.
Alpha Cognition Inc. (ACOG) - Yahoo Finance
See More Alpha Cognition Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Alpha Cognition? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Alpha Cognition and other key companies, straight to your email.

About Alpha Cognition

Alpha Cognition (NASDAQ:ACOG), Inc. is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. The company was founded in 2000 and is headquartered in Vancouver, Canada.

View Alpha Cognition Profile

More Earnings Resources from MarketBeat